Learning Objectives:

1.  Administered T cells can mediate therapeutic anti-tumor effects.

2.  T-Cells can be genetically engineered to be tumor-reactive.

3.  Synthetic biology allows for constructing novel chimeric proteins that enhance activity.

Session date: 
Monday, October 11, 2021 - 12:00pm to 1:00pm
Location: 
Virtually
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Philip Greenberg, MD